Anat Hakim
Executive VP, General Counsel & SecretaryMs. Anat Hakim, J.D., serves as General Counsel at Eli Lilly and Company since February 03, 2020 and had been its Senior Vice President since February 03, 2020. She serves as Secretary of Eli Lilly and Company since February 2020 and serves as its Executive Vice President. She joined Eli Lilly and Company in February 03, 2020. She served as Executive Vice President, General Counsel and Secretary of WellCare Health Plans, Inc. since 2018 until 2020. Ms. Hakim had been Senior Vice President, General Counsel and Secretary of WellCare Health Plans, Inc. since September 26, 2016 until 2018. She served as Director at Missouri Care, Incorporated. Ms. Hakim is responsible for leading the WellCare's legal department. Prior to that, from August 2010 to September 2016, she served with Abbott Laboratories. She served as Divisional Vice President, Associate General Counsel, Litigation for Abbott Laboratories since January 2013, a global diagnostics, medical device, nutrition and branded generic pharmaceuticals manufacturer. In this role, she had oversight of Abbott Laboratories' commercial litigation; intellectual property litigation; government investigations; compliance internal investigations and remediation; and labor and employment counseling. From August 2010 to December 2012, she served as Abbott’s Divisional Vice President, IP Litigation. Prior to joining Abbott, she spent with Foley & Lardner, LLP, an international law firm, as an equity partner, where she focused on patent, trademark, trade secret and complex commercial lawsuits. From February 2002 to July 2010, she was a partner at Foley & Lardner LLP. Before joining Foley & Lardner, Ms. Hakim served as an associate with the law firm Latham & Watkins from August 1993 to November 1997. She holds a B.A. in Political Science from the University of Wisconsin-Madison in 1990 and a J.D. from Harvard University. Ms. Hakim received her law degree from Harvard Law School in 1993.
Positions
- Company NameEli Lilly and CompanyStock CodeLLYPositionExecutive VP, General Counsel & SecretaryColleagues
- DADavid A. RicksChairman, President & CEO
- LELucas E. MontarceExecutive VP & CFO
- DMDaniel M. SkovronskyChief Scientific & Product Officer and President of Lilly Research Laboratories
- JSJacob S. Van NaardenExecutive VP, President of Lilly Oncology & Head of Corporate Business Development
- STSidney TaurelChairman Emeritus
- RARalph AlvarezIndependent Director
- JRJuan Ricardo LucianoLead Independent Director
- JJJamere JacksonIndependent Director
